PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21824498-6	2011	Interestingly, pre-treatment of prostate cancer cells with diazoxide (a chemical activator of PKCepsilon), or KAE1-1 (a cell-permeable, octa-peptide specific activator of PKCepsilon) prevents 5-LOX inhibition-induced apoptosis, which indicates that inhibition of 5-LOX triggers apoptosis in prostate cancer cells via down-regulation of PKCepsilon.	Diazoxide	59-68	protein kinase C epsilon	Homo sapiens	94-104	
28846530-2	2017	Diazoxide is suggested to act through protein kinase Cepsilon (PKCepsilon) activation.	Diazoxide	0-9	protein kinase C epsilon	Homo sapiens	38-61	
16720572-4	2006	We confirmed previous findings that diazoxide and activators of PKG or protein kinase C (PKC) inhibited MPT opening.	Diazoxide	36-45	protein kinase C epsilon	Homo sapiens	89-92	
12940889-15	2003	Although PKC-epsilon was activated during treatment with adenosine, diazoxide or SNAP alone, it was inactivated after washout.	Diazoxide	68-77	protein kinase C epsilon	Homo sapiens	9-20	
28846530-2	2017	Diazoxide is suggested to act through protein kinase Cepsilon (PKCepsilon) activation.	Diazoxide	0-9	protein kinase C epsilon	Homo sapiens	63-73